SPX3,845.08+13.69 0.36%
DIA310.41+0.70 0.23%
IXIC11,361.85+39.61 0.35%

Update: Fulcrum Says Initial FTX-6058 Trial Data in Sickle Cell Disease 'Compelling'; Shares Tumble

MT Newswires · 06/10/2022 08:55

Please log in to view news